Core Laboratories (CLB) Holdings Cut by Cubist Systematic Strategies LLC

Cubist Systematic Strategies LLC lowered its stake in shares of Core Laboratories (NYSE:CLB) by 29.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,304 shares of the oil and gas company’s stock after selling 1,372 shares during the period. Cubist Systematic Strategies LLC’s holdings in Core Laboratories were worth $326,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of CLB. Schwab Charles Investment Management Inc. raised its position in shares of Core Laboratories by 6.7% during the second quarter. Schwab Charles Investment Management Inc. now owns 139,549 shares of the oil and gas company’s stock worth $14,133,000 after purchasing an additional 8,774 shares during the period. Robeco Institutional Asset Management B.V. acquired a new stake in shares of Core Laboratories during the second quarter worth about $1,250,000. Andra AP fonden acquired a new stake in shares of Core Laboratories during the second quarter worth about $810,000. Airain ltd acquired a new stake in shares of Core Laboratories during the second quarter worth about $235,000. Finally, Neuberger Berman Group LLC raised its position in shares of Core Laboratories by 6,220.7% during the second quarter. Neuberger Berman Group LLC now owns 251,313 shares of the oil and gas company’s stock worth $25,450,000 after purchasing an additional 247,337 shares during the period.

CLB has been the topic of a number of research analyst reports. Deutsche Bank initiated coverage on Core Laboratories in a research report on Tuesday, October 10th. They set a “buy” rating and a $109.00 price target on the stock. ABN Amro raised Core Laboratories from a “hold” rating to a “buy” rating in a research report on Wednesday, October 25th. Loop Capital dropped their price target on Core Laboratories from $125.00 to $115.00 and set a “buy” rating on the stock in a research report on Wednesday, October 25th. Royal Bank of Canada reaffirmed a “buy” rating on shares of Core Laboratories in a research report on Wednesday, October 18th. Finally, Zacks Investment Research raised Core Laboratories from a “sell” rating to a “hold” rating in a research report on Wednesday, October 25th. Three research analysts have rated the stock with a sell rating, six have issued a hold rating and six have given a buy rating to the stock. Core Laboratories presently has a consensus rating of “Hold” and a consensus price target of $110.20.

Shares of Core Laboratories (NYSE CLB) opened at $113.09 on Thursday. Core Laboratories has a 1 year low of $86.55 and a 1 year high of $125.83. The stock has a market capitalization of $4,944.06, a P/E ratio of 64.99 and a beta of 1.56. The company has a debt-to-equity ratio of 1.53, a current ratio of 2.18 and a quick ratio of 1.81.

Core Laboratories (NYSE:CLB) last announced its earnings results on Monday, October 23rd. The oil and gas company reported $0.48 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.44 by $0.04. Core Laboratories had a return on equity of 52.89% and a net margin of 12.06%. The business had revenue of $166.20 million for the quarter, compared to analyst estimates of $160.94 million. During the same quarter last year, the firm earned $0.38 EPS. Core Laboratories’s revenue for the quarter was up 1.4% compared to the same quarter last year. equities analysts expect that Core Laboratories will post 1.99 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This piece of content was first posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The correct version of this piece of content can be viewed at https://www.com-unik.info/2018/01/04/core-laboratories-clb-holdings-cut-by-cubist-systematic-strategies-llc.html.

Core Laboratories Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Institutional Ownership by Quarter for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit